Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Roche Acquires Two Diagnostics Firms

by Ann M. Thayer
August 24, 2015 | A version of this story appeared in Volume 93, Issue 33

Roche’s diagnostic division will pay up to $425 million to acquire California-based GeneWeave BioSciences. The privately held company develops clinical microbiology diagnostics around a technology it calls Smarticles. It is able to identify multi-drug-resistant organisms and assesses antibiotic susceptibility directly from clinical samples. Separately, Roche will also acquire Massachusetts-based Kapa Biosystems for an undisclosed amount. The firm uses protein engineering to generate, screen, and optimize enzymes for next-generation sequencing and polymerase chain reaction technology applications.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.